ATE473235T1 - Das biomolekültransduktionsmotiv sim-2-btm und dessen verwendung - Google Patents

Das biomolekültransduktionsmotiv sim-2-btm und dessen verwendung

Info

Publication number
ATE473235T1
ATE473235T1 AT03703396T AT03703396T ATE473235T1 AT E473235 T1 ATE473235 T1 AT E473235T1 AT 03703396 T AT03703396 T AT 03703396T AT 03703396 T AT03703396 T AT 03703396T AT E473235 T1 ATE473235 T1 AT E473235T1
Authority
AT
Austria
Prior art keywords
btm
sim
motif
therapy
vaccines
Prior art date
Application number
AT03703396T
Other languages
English (en)
Inventor
Sang-Kyou Lee
Seung-Kyou Lee
Byung-Fhy Suh
Wook-Jin Chae
Jong-Bum Kim
Jong-Sun Lee
Jung-Jin Yang
Original Assignee
Sang-Kyou Lee
Forhumantech Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sang-Kyou Lee, Forhumantech Co Ltd filed Critical Sang-Kyou Lee
Application granted granted Critical
Publication of ATE473235T1 publication Critical patent/ATE473235T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Transplantation (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Fats And Perfumes (AREA)
AT03703396T 2002-01-19 2003-01-20 Das biomolekültransduktionsmotiv sim-2-btm und dessen verwendung ATE473235T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR1020020003184A KR20030062789A (ko) 2002-01-19 2002-01-19 생체분자 전달 펩타이드 ｓｉｍ2-ｂｔｍ 및 이것을포함하는 생명공학제품
PCT/KR2003/000121 WO2003059940A1 (en) 2002-01-19 2003-01-20 Biomolecule transduction motif sim-2-btm and the use thereof

Publications (1)

Publication Number Publication Date
ATE473235T1 true ATE473235T1 (de) 2010-07-15

Family

ID=19718641

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03703396T ATE473235T1 (de) 2002-01-19 2003-01-20 Das biomolekültransduktionsmotiv sim-2-btm und dessen verwendung

Country Status (8)

Country Link
US (1) US7354737B2 (de)
EP (1) EP1468011B1 (de)
JP (1) JP4361370B2 (de)
KR (2) KR20030062789A (de)
AT (1) ATE473235T1 (de)
AU (1) AU2003206161A1 (de)
DE (1) DE60333254D1 (de)
WO (1) WO2003059940A1 (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20030062788A (ko) 2002-01-19 2003-07-28 포휴먼텍(주) 생체분자 전달 펩타이드 ｍｐｈ1-ｂｔｍ 및 이것을포함하는 생명공학제품
KR100591936B1 (ko) * 2002-11-12 2006-06-22 포휴먼텍(주) 세포내 ｄｎａ／ｒｎａ 전달 방법, 및 이것의 기초 및임상학적 응용
KR100897915B1 (ko) 2004-11-03 2009-05-18 포휴먼텍(주) 경피전달을 위한 약제 조성물
ATE478676T1 (de) 2005-11-04 2010-09-15 Forhumantech Co Ltd Verfahren zur abgabe von fusionspolypeptid in eine zelle
JP2009532017A (ja) * 2006-02-10 2009-09-10 ザ レジェンツ オブ ザ ユニヴァースティ オブ カリフォルニア ＰＴＤ／ＣＰＰＳへのｄｓＲＮＡ結合ドメイン融合体によるｓｉＲＮＡの導入可能な送達
JP2009544688A (ja) 2006-07-24 2009-12-17 フォーヒューマンテック カンパニー リミテッド 虚血性疾患の緩和及び治療のための医薬組成物並びにそれを伝達するための方法
WO2009032148A1 (en) * 2007-08-29 2009-03-12 Tufts University Methods of making and using a cell penetrating peptide for enhanced delivery of nucleic acids, proteins, drugs, and adenovirus to tissues and cells, and compositions and kits
US7981446B2 (en) 2007-11-26 2011-07-19 Forhumantech. Co., Ltd. Pharmaceutical compositions and methods for delivering nucleic acids into cells
JP5897002B2 (ja) 2010-07-07 2016-04-13 セルラー ダイナミクス インターナショナル， インコーポレイテッド プログラミングによる内皮細胞の産生
WO2012109208A2 (en) 2011-02-08 2012-08-16 Cellular Dynamics International, Inc. Hematopoietic precursor cell production by programming
US9637723B2 (en) 2012-05-30 2017-05-02 Cornell University Q Generation of functional and durable endothelial cells from human amniotic fluid-derived cells
JP2015529073A (ja) 2012-08-20 2015-10-05 ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア 生物可逆性基を有するポリヌクレオチド

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5194596A (en) 1989-07-27 1993-03-16 California Biotechnology Inc. Production of vascular endothelial cell growth factor
US5350836A (en) 1989-10-12 1994-09-27 Ohio University Growth hormone antagonists
EP1290217A2 (de) * 2000-02-04 2003-03-12 Aeomica, Inc. Methoden und apparat zur voraussage, bestätigung und darstellung funktionaler information, abgeleitet von genomischen sequenzen
CA2453907A1 (en) * 2000-08-04 2002-02-14 Florida Atlantic University Association of sim2 with cancer
KR100591936B1 (ko) * 2002-11-12 2006-06-22 포휴먼텍(주) 세포내 ｄｎａ／ｒｎａ 전달 방법, 및 이것의 기초 및임상학적 응용

Also Published As

Publication number Publication date
KR20040085154A (ko) 2004-10-07
EP1468011A4 (de) 2005-10-12
JP4361370B2 (ja) 2009-11-11
KR100978344B1 (ko) 2010-08-26
EP1468011A1 (de) 2004-10-20
KR20030062789A (ko) 2003-07-28
EP1468011B1 (de) 2010-07-07
US20050222386A1 (en) 2005-10-06
DE60333254D1 (de) 2010-08-19
AU2003206161A1 (en) 2003-07-30
WO2003059940A1 (en) 2003-07-24
JP2005532037A (ja) 2005-10-27
US7354737B2 (en) 2008-04-08

Similar Documents

Publication Publication Date Title
ATE471336T1 (de) Das biomolekültransduktionsmotiv mph-1-btm und dessen verwendung
Riminucci et al. Fibrous dysplasia as a stem cell disease
Zuris et al. Cationic lipid-mediated delivery of proteins enables efficient protein-based genome editing in vitro and in vivo
DE60333254D1 (de) Das biomolekültransduktionsmotiv sim-2-btm und dessen verwendung
MX357691B (es) Il-15 y il-15r-alfa mejoradas para expresion en celulas mamiferas.
FR17C1045I1 (fr) Nouvelles molecules b7-4 et leurs utilisations
PH12020551039A1 (en) Non-viral dna vectors and uses thereof for antibody and fusion protein production
DK1218504T3 (da) GL50 molekyler og anvendelser deraf
Lengler et al. Antagonistic action of Six3 and Prox1 at the γ-crystallin promoter
ATE550356T1 (de) Chimäre t-zellen-rezeptoren sowie entsprechende materialien und verwendungsverfahren
MY154826A (en) Fusion protein capable of binding vegf
MX9206376A (es) Liberacion de proteinas por terapia genica
Callahan et al. Heat shock up-regulates lmp2 and lmp7 and enhances presentation of immunoproteasome-dependent epitopes
WO2006007560A3 (en) Targeted protein replacement for the treatment of lysosomal storage disorders
Song et al. Stat1 and SUMO modification
Herbert et al. Sending messages in moving cells: mRNA localization and the regulation of cell migration
Hosseini et al. Effect of RGD coupled MDA-7/IL-24 on apoptosis induction in a hepatocellular carcinoma cell line
Qian et al. Long-acting human interleukin 2 bioconjugate modified with fatty acids by sortase A
Han et al. Intratumoural vaccination via checkpoint degradation-coupled antigen presentation
Geng et al. Transcriptional regulation of CD1D1 by Ets family transcription factors
EP1208196A4 (de) 15571, ein neues gpcr-ähnliches molekül der secretin-ähnlichen familie und dessen verwendungen
Vukmirica et al. The Rab4A effector protein Rabip4 is involved in migration of NIH 3T3 fibroblasts
Xiong et al. Identification of a functional nuclear localization signal within the human USP22 protein
DK1807518T3 (da) Rekombinant alfa-fetoprotein, fremgangsmåde og midler til fremstilling heraf, sammensætninger baseret derpå og anvendelse heraf
EP1277843A3 (de) Neue humane Gene und Genexpressionsprodukte die in Zusammenhang mit Darmkrebs stehen

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties